Adam de Havenon1, Alicia Castonguay2, Raul Nogueira2, Thanh N Nguyen2, Joey English2, Sudhakar Reddy Satti2, Erol Veznedaroglu2, Jeffrey L Saver2, J Mocco2, Pooja Khatri2, Eva Mistry2, Osama O Zaidat2. 1. From the Department of Neurology (A.d.H.), University of Utah, Salt Lake City; Department of Neurology (A.C.), University of Toledo, OH; Department of Neurology, Neurosurgery, and Radiology (R.N.), Emory University, Atlanta, GA; Department of Neurology, Neurosurgery, and Radiology (T.N.N.), Boston Medical Center, MA; California Pacific Medical Center (J.E.), San Francisco; Department of Neurointerventional Surgery (S.R.S.), Christiana Care Health System, Newark, DE; Department of Neurosurgery (E.V.), Drexel Neurosciences Institute, Philadelphia, PA; Department of Neurology (J.L.S.), University of California, Los Angeles; Department of Neurosurgery (J.M.), Mt. Sinai, New York, NY; Department of Neurology (P.K.), University of Cincinnati, OH; Department of Neurology (E.M.), Vanderbilt Medical Center, Nashville, TN; and Department of Neurology (O.O.Z.), Mercy Health-St. Vincent Medical Center, Toledo, OH. adam.dehavenon@hsc.utah.edu. 2. From the Department of Neurology (A.d.H.), University of Utah, Salt Lake City; Department of Neurology (A.C.), University of Toledo, OH; Department of Neurology, Neurosurgery, and Radiology (R.N.), Emory University, Atlanta, GA; Department of Neurology, Neurosurgery, and Radiology (T.N.N.), Boston Medical Center, MA; California Pacific Medical Center (J.E.), San Francisco; Department of Neurointerventional Surgery (S.R.S.), Christiana Care Health System, Newark, DE; Department of Neurosurgery (E.V.), Drexel Neurosciences Institute, Philadelphia, PA; Department of Neurology (J.L.S.), University of California, Los Angeles; Department of Neurosurgery (J.M.), Mt. Sinai, New York, NY; Department of Neurology (P.K.), University of Cincinnati, OH; Department of Neurology (E.M.), Vanderbilt Medical Center, Nashville, TN; and Department of Neurology (O.O.Z.), Mercy Health-St. Vincent Medical Center, Toledo, OH.
Abstract
BACKGROUND AND OBJECTIVES: To determine the impact of endovascular therapy for large vessel occlusion stroke in patients with vs those without premorbid disability. METHODS: We performed a post hoc analysis of the TREVO Stent-Retriever Acute Stroke (TRACK) Registry, which collected data on 634 consecutive patients with stroke treated with the Trevo device as first-line endovascular thrombectomy (EVT) at 23 centers in the United States. We included patients with internal carotid or middle cerebral (M1/M2 segment) artery occlusions, and the study exposure was patient- or caregiver-reported premorbid modified Rank Scale (mRS) score ≥2 (premorbid disability [PD]) vs premorbid mRS score of 0 to 1 (no PD [NPD]). The primary outcome was no accumulated disability, defined as no increase in 90-day mRS score from the patient's premorbid mRS score. RESULTS: Of the 634 patients in TRACK, 407 patients were included in our cohort, of whom 53 (13.0%) had PD. The primary outcome of no accumulated disability was achieved in 37.7% (20 of 53) of patients with PD and 16.7% (59 of 354) of patients with NPD (p < 0.001), while death occurred in 39.6% (21 of 53) and 14.1% (50 of 354) (p < 0.001), respectively. The adjusted odds ratio of no accumulated disability for patients with PD was 5.2 (95% confidence interval [CI] 2.4-11.4, p < 0.001) compared to patients with NPD. However, the adjusted odds ratio for death in patients with PD was 2.90 (95% CI 1.38-6.09, p = 0.005). DISCUSSION: In this study of patients with anterior circulation acute ischemic stroke treated with EVT, we found that PD was associated with a higher probability of not accumulating further disability compared to patients with NPD but also with higher probability of death. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that in anterior circulation acute ischemic stroke treated with EVT, patients with PD compared to those without disability were more likely not to accumulate more disability but were more likely to die.
BACKGROUND AND OBJECTIVES: To determine the impact of endovascular therapy for large vessel occlusion stroke in patients with vs those without premorbid disability. METHODS: We performed a post hoc analysis of the TREVO Stent-Retriever Acute Stroke (TRACK) Registry, which collected data on 634 consecutive patients with stroke treated with the Trevo device as first-line endovascular thrombectomy (EVT) at 23 centers in the United States. We included patients with internal carotid or middle cerebral (M1/M2 segment) artery occlusions, and the study exposure was patient- or caregiver-reported premorbid modified Rank Scale (mRS) score ≥2 (premorbid disability [PD]) vs premorbid mRS score of 0 to 1 (no PD [NPD]). The primary outcome was no accumulated disability, defined as no increase in 90-day mRS score from the patient's premorbid mRS score. RESULTS: Of the 634 patients in TRACK, 407 patients were included in our cohort, of whom 53 (13.0%) had PD. The primary outcome of no accumulated disability was achieved in 37.7% (20 of 53) of patients with PD and 16.7% (59 of 354) of patients with NPD (p < 0.001), while death occurred in 39.6% (21 of 53) and 14.1% (50 of 354) (p < 0.001), respectively. The adjusted odds ratio of no accumulated disability for patients with PD was 5.2 (95% confidence interval [CI] 2.4-11.4, p < 0.001) compared to patients with NPD. However, the adjusted odds ratio for death in patients with PD was 2.90 (95% CI 1.38-6.09, p = 0.005). DISCUSSION: In this study of patients with anterior circulation acute ischemic stroke treated with EVT, we found that PD was associated with a higher probability of not accumulating further disability compared to patients with NPD but also with higher probability of death. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that in anterior circulation acute ischemic stroke treated with EVT, patients with PD compared to those without disability were more likely not to accumulate more disability but were more likely to die.
Authors: Gregory W Albers; Michael P Marks; Stephanie Kemp; Soren Christensen; Jenny P Tsai; Santiago Ortega-Gutierrez; Ryan A McTaggart; Michel T Torbey; May Kim-Tenser; Thabele Leslie-Mazwi; Amrou Sarraj; Scott E Kasner; Sameer A Ansari; Sharon D Yeatts; Scott Hamilton; Michael Mlynash; Jeremy J Heit; Greg Zaharchuk; Sun Kim; Janice Carrozzella; Yuko Y Palesch; Andrew M Demchuk; Roland Bammer; Philip W Lavori; Joseph P Broderick; Maarten G Lansberg Journal: N Engl J Med Date: 2018-01-24 Impact factor: 91.245
Authors: Robert-Jan B Goldhoorn; Merel Verhagen; Diederik W J Dippel; Aad van der Lugt; Hester F Lingsma; Yvo B W E M Roos; Charles B L M Majoie; Jan Albert Vos; Jelis Boiten; Wim H van Zwam; Robert J van Oostenbrugge; Ido van den Wijngaard Journal: Stroke Date: 2018-10 Impact factor: 7.914
Authors: Steven R Messé; Pooja Khatri; Mathew J Reeves; Eric E Smith; Jeffrey L Saver; Deepak L Bhatt; Maria V Grau-Sepulveda; Margueritte Cox; Eric D Peterson; Gregg C Fonarow; Lee H Schwamm Journal: Neurology Date: 2016-09-14 Impact factor: 9.910
Authors: Osama O Zaidat; Alicia C Castonguay; Raul G Nogueira; Diogo C Haussen; Joey D English; Sudhakar R Satti; Jennifer Chen; Hamed Farid; Candace Borders; Erol Veznedaroglu; Mandy J Binning; Ajit Puri; Nirav A Vora; Ron F Budzik; Guilherme Dabus; Italo Linfante; Vallabh Janardhan; Amer Alshekhlee; Michael G Abraham; Randall Edgell; Muhammad Asif Taqi; Ramy El Khoury; Maxim Mokin; Aniel Q Majjhoo; Mouhammed R Kabbani; Michael T Froehler; Ira Finch; Sameer A Ansari; Roberta Novakovic; Thanh N Nguyen Journal: J Neurointerv Surg Date: 2017-09-29 Impact factor: 5.836
Authors: Marek Sykora; Patrik Michel; Davide Strambo; Stefan Krebs; Julia Ferrari; Alexandra Posekany; Dominika Mikšová; Konstantin Hermann; Thomas Gattringer; Elke Gizewski; Hannes Deutschmann; Christian Neumann; Wilfried Lang Journal: J Stroke Date: 2022-09-30 Impact factor: 8.632
Authors: Maximilian I Sprügel; Jochen A Sembill; Svenja Kremer; Stefan T Gerner; Michael Knott; Stefan Hock; Tobias Engelhorn; Arnd Dörfler; Hagen B Huttner; Stefan Schwab Journal: JAMA Netw Open Date: 2022-08-01
Authors: Thomas Meinel; Christine Lerch; Urs Fischer; Morin Beyeler; Adnan Mujanovic; Christoph Kurmann; Bernhard Siepen; Adrian Scutelnic; Madlaine Müller; Martina Goeldlin; Nebiyat Filate Belachew; Tomas Dobrocky; Jan Gralla; David Seiffge; Simon Jung; Marcel Arnold; Roland Wiest; Raphael Meier; Johannes Kaesmacher Journal: Neurology Date: 2022-07-08 Impact factor: 11.800